Donald Trump hospital covid-19 president patient Coronavirus Donald Trump

FDA approves emergency use of Regeneron COVID-19 monoclonal antibody therapy used to treat President Trump

Reading now: 772
www.fox29.com

FILE - View of Corporate and Research and Development Headquarters of Regeneron Pharmaceuticals, Inc. (Lev Radin/Pacific Press/LightRocket via Getty Images)The U.S.

Food and Drug Administration has issued an emergency use authorization (EUA) of two more monoclonal antibody treatments for mild cases of COVID-19, according to a news release.

The same dual therapy was used to treat President Donald Trump when he was diagnosed with COVID-19 in October, the FDA confirmed.Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as the novel coronavirus, according to the FDA.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA